|
Children's Oncology Group Phase 1 / Pilot Consortium
|
2U01CA097452-06
|
$2,573,434
|
$377,523
|
ADAMSON, PETER
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Clinical study of GMCI in Pancreatic Cancer
|
5R43CA119847-02
|
$376,666
|
$94,167
|
Aguilar-Cordova, Estuardo
|
ADVANTAGENE, INC
|
|
Participation in the Eastern Cooperative Oncology Group
|
5U10CA107868-04
|
$234,166
|
$25,758
|
AISNER, JOSEPH
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
Immuno/Immunogene Therapies for Thoracic Malignancies
|
5P01CA066726-11
|
$1,181,405
|
$236,281
|
Albelda, STEVEN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Blood Flow MRI for Monitoring Glioma Angiogenesis
|
5R01CA115745-02
|
$333,543
|
$83,386
|
ALSOP, DAVID
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Santa Rosa Memorial Hospital Regional CCOP
|
3U10CA063850-12S2
|
$131,400
|
$2,628
|
ANDERSON, IAN
|
SANTA ROSA MEMORIAL HOSPITAL
|
|
Outcomes of Omission of Radiation With Lumpectomy (BCS) Among Low-Income Women
|
5R01CA121317-02
|
$138,265
|
$138,265
|
ANDERSON, ROGER
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
Children's Oncology Group Statistics and Data Center
|
5U10CA098413-05
|
$5,859,839
|
$1,464,960
|
ANDERSON, JAMES
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Descriptive Studies and Record Linkage
|
Z01 CP010183
|
$674,691
|
$844
|
Anderson
|
DCEG (NCI)
|
|
Eastern Cooperative Oncology Group
|
2U10CA080775-09
|
$128,678
|
$14,155
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Southeast Cancer Control Consortium, Inc
|
3U10CA045808-21S1
|
$170,000
|
$3,400
|
ATKINS, JAMES
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
DF/HCC Renal Cancer SPORE
|
5P50CA101942-05
|
$2,330,598
|
$466,120
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Southeast Cancer Control Consortium, Inc
|
5U10CA045808-21
|
$1,860,642
|
$37,213
|
ATKINS, JAMES
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
Eastern Cooperative Oncology Group Studies
|
5U10CA014548-33
|
$413,938
|
$45,533
|
AVERBOOK, BRUCE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Cancer Care Outcomes Research & Surveillance Consortium
|
3U01CA093324-05S4
|
$47,445
|
$11,861
|
AYANIAN, JOHN
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
|
SAN JUAN MB COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA052667-17
|
$484,826
|
$19,393
|
BAEZ, LUIS
|
SAN JUAN CITY HOSPITAL
|
|
Southwest Oncology Group
|
2U10CA027057-28
|
$255,214
|
$2,552
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Southwest Oncology Group
|
3U10CA027057-28S1
|
$43,000
|
$430
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Interim SWOG Committee Renewals (Breast, Head & Neck, Leukemia)
|
3U10CA032102-28S1
|
$187,055
|
$1,871
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
SOUTHWEST ONCOLOGY GROUP - OPERATIONS OFFICE
|
3U10CA032102-28S2
|
$159,600
|
$1,596
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
SOUTHWEST ONCOLOGY GROUP - OPERATIONS OFFICE
|
3U10CA032102-28S3
|
$316,222
|
$3,162
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
SOUTHWEST ONCOLOGY GROUP - OPERATIONS OFFICE
|
5U10CA032102-28
|
$9,423,958
|
$94,240
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Islolated Hepatic Perfusion with Oxaliplatin
|
5R21CA115059-02
|
$255,944
|
$63,986
|
BARTLETT, DAVID
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
WUMC-Cancer and Leukemia Group B
|
5U10CA077440-10
|
$334,381
|
$3,344
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-45S1
|
$231,549
|
$2,315
|
BAYLIN, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-45S2
|
$126,362
|
$1,264
|
BAYLIN, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
5P30CA006973-45
|
$7,564,613
|
$75,646
|
BAYLIN, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
2U10CA035119-23
|
$1,740,827
|
$52,225
|
BEARDEN, JAMES
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
Psychoneuroimmunology-Immunotherapy interactions
|
1R01CA125456-01A1
|
$180,696
|
$90,348
|
Ben-Eliyahu, Shamgar
|
TEL AVIV UNIVERSITY
|
|
PSMA-Dye Surgical Margin Imaging During Prostatectomy
|
5R44CA107908-04
|
$742,499
|
$742,499
|
BENARON, DAVID
|
SPECTROS CORPORATION
|
|
Eastern Cooperative Oncology Group Clinical Trials
|
5U10CA017145-32
|
$456,370
|
$50,201
|
BENSON, AL
|
NORTHWESTERN UNIVERSITY
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S1
|
$124,531
|
$3,736
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S3
|
$137,869
|
$4,136
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S4
|
$232,326
|
$6,970
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S5
|
$250,000
|
$7,500
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-43
|
$11,526,509
|
$345,795
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Imaging and Tissue Biomarkers in the Treatment of Brain Tumors
|
1P01CA118816-01A2
|
$2,325,890
|
$790,803
|
BERGER, MITCHEL
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Geisinger Clinical Oncology Program
|
5U10CA035448-24
|
$458,852
|
$41,297
|
BERNATH, ALBERT
|
GEISINGER MEDICAL CENTER
|
|
Cancer Center Support Grant
|
3P30CA072720-11S1
|
$108,846
|
$3,265
|
BERTINO, JOSEPH
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
Cancer Center Support Grant
|
3P30CA072720-11S2
|
$127,296
|
$3,819
|
BERTINO, JOSEPH
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
Cancer Center Support Grant
|
5P30CA072720-11
|
$3,128,377
|
$93,851
|
BERTINO, JOSEPH
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
Multimodality virtual endoscopy with hybrid PET/CT units
|
5R21CA109564-02
|
$139,290
|
$27,858
|
BIDAUT, LUC
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Structure, Process, and Outcomes in Cancer Surgery
|
3R01CA098481-04S1
|
$90,107
|
$90,107
|
Birkmeyer, John
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Improved Cryosurgical Destruction of Prostate Cancer
|
5R01CA075284-08
|
$307,035
|
$307,035
|
BISCHOF, JOHN
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
Gynecologic Oncology Group Statistical and Data Center
|
5U10CA037517-23
|
$4,654,021
|
$744,643
|
BLESSING, JOHN
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Cancer and Leukemia Group B - The Ohio State University
|
5U10CA077658-10
|
$434,962
|
$4,350
|
BLOOMFIELD, CLARA
|
OHIO STATE UNIVERSITY
|
|
Heat Activated Gene Therapy Using Radiomimetic CdtB
|
5R01CA099178-04
|
$248,414
|
$62,104
|
Borrelli, Michael
|
UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK
|
|
ADJUVANT TRIAL WITH SOY AFTER RADICAL PROSTATECTOMY
|
3R01CA116195-03S1
|
$86,800
|
$86,800
|
BOSLAND, MAARTEN
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
PHASE II TRIAL OF SOY PRIOR TO RADICAL PROSTATECTOMY
|
5R01CA103215-05
|
$258,582
|
$64,646
|
BOSLAND, MAARTEN
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
ADJUVANT TRIAL WITH SOY AFTER RADICAL PROSTATECTOMY
|
5R01CA116195-03
|
$243,068
|
$243,068
|
BOSLAND, MAARTEN
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
Total relevant funding to Surgery for this search: $63,184,035
|